414
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Cost of Diabetic Foot Ulcer Management in China: A 7-Year Single-Center Retrospective Review

ORCID Icon, , , , , & show all
Pages 4249-4260 | Published online: 10 Nov 2020

References

  • Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376:2367–2375. doi:10.1056/NEJMra1615439
  • Nieto Gil P, Ortega Avila AB, Pardo Rios M, et al. Hospitalisation cost of patients with diabetic foot ulcers in valencia (Spain) in the period 2009–2013: a retrospective descriptive analysis. Int J Environ Res Public Health. 2018;15:1831. doi:10.3390/ijerph15091831
  • Wang J, Zhou Y, Li YP, et al. extensive serum biomarker analysis before and after treatment in healing of diabetic foot ulcers using a cytokine antibody array. Cytokine. 2020;22(133):155173. doi:10.1016/j.cyto.2020.155173
  • Sen P, Demirdal T, Emir B. Meta-analysis of risk factors for amputation in diabetic foot infections. Diabetes Metab Res Rev. 2019;35:e3165. doi:10.1002/dmrr.3165
  • Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet. 2003;361:1545–1551. doi:10.1016/S0140-6736(03)13169-8
  • Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–228. doi:10.1001/jama.293.2.217
  • IDF Diabetes Atlas, Eighth Edition 2017. International Diabetes Federation. 2018. Available from: http://www.diabetesatlas.org. Accessed October 19, 2020.
  • Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe: baseline results from the Eurodiale study. Diabetologia. 2007;50:18–25. doi:10.1007/s00125-006-0491-1
  • Uçkay I, Gariani K, Pataky Z, et al. Diabetic foot infections: state-of-the-art. Diabetes Obes Metab. 2014;16:305–316. doi:10.1111/dom.12190
  • Rastogi A, Goyal G, Kesavan R, et al. Long term outcomes after incident diabetic foot ulcer: multicenter large cohort prospective study (EDI-FOCUS investigators) epidemiology of diabetic foot complications study: epidemiology of diabetic foot complications study. Diabetes Res Clin Pract. 2020;162:108113. doi:10.1016/j.diabres.2020.108113
  • Won SH, Chung CY, Park MS, et al. Risk factors associated with amputation-free survival in patient with diabetic foot ulcers. Yonsei Med J. 2014;55:1373–1378. doi:10.3349/ymj.2014.55.5.1373
  • Walsh JW, Hoffstad OJ, Sullivan MO, et al. Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med. 2016;33:1493–1498. doi:10.1111/dme.13054
  • Oh TS, Lee HS, Hong JP. Diabetic foot reconstruction using free flaps increases 5-year-survival rate. J Plast Reconstr Aesthet Surg. 2013;66:243–250. doi:10.1016/j.bjps.2012.09.024
  • Harrington C, Zagari MJ, Corea J, et al. A cost analysis of diabetic lower-extremity ulcers. Diabetes Care. 2000;23:1333–1338. doi:10.2337/diacare.23.9.1333
  • Cavanagh P, Attinger C, Abbas Z, et al. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab Res Rev. 2012;28:107–111. doi:10.1002/dmrr.2245
  • Chow I, Lemos EV, Einarson TR. Management and prevention of diabetic foot ulcers and infections: a health economic review. Pharmacoeconomics. 2008;26:1019–1035. doi:10.2165/0019053-200826120-00005
  • Prompers L, Huijberts M, Schaper N, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale study. Diabetologia. 2008;51:1826–1834. doi:10.1007/s00125-008-1089-6
  • Stockl K, Vanderplas A, Tafesse E, et al. Costs of lower-extremity ulcers among patients with diabetes. Diabetes Care. 2004;27:2129–2134. doi:10.2337/diacare.27.9.2129
  • Habacher W, Rakovac I, Görzer E, et al. A model to analyse costs and benefits of intensified diabetic foot care in Austria. J Eval Clin Pract. 2007;13:906–912.
  • Ray JA, Valentine WJ, Secnik K, et al. Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain. Curr Med Res Opin. 2005;21:1617–1629. doi:10.1185/030079905X65349
  • Chun DI, Kim S, Kim J, et al. Epidemiology and burden of diabetic foot ulcer and peripheral arterial disease in Korea. J Clin Med. 2019;8:748–755. doi:10.3390/jcm8050748
  • Jönsson B. Revealing the cost of type II diabetes in Europe. Diabetologia. 2002;45:S5–S12. doi:10.1007/s00125-002-0858-x
  • De Alcalá Martínez D, Aguayo JL, Flores B, et al. Resultados de la hospitalización en pacientes con pie diabético. Cir Españ. 2003;74:92–96. doi:10.1016/S0009-739X(03)72195-2
  • Anderson PL, Gelijns A, Moskowitz A, et al. Understanding trends in inpatient surgical volume: vascular interventions, 1980–2000. J Vasc Surg. 2004;39:1200–1208. doi:10.1016/j.jvs.2004.02.039
  • Goldberg JB, Goodney PP, Cronenwett JL, et al. The effect of risk and race on lower extremity amputations among medicare diabetic patients. J Vasc Surg. 2012;56:1663–1668. doi:10.1016/j.jvs.2012.05.100
  • Hicks CW, Selvarajah S, Mathioudakis N, et al. Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers. J Vasc Surg. 2014;60:1247–1254. doi:10.1016/j.jvs.2014.05.009
  • Behrendt CA, Sigvant B, Szeberin Z, et al. International variations in amputation practice: a V ASCUNET report. Eur J Vasc Endovasc Surg. 2018;56:391–399. doi:10.1016/j.ejvs.2018.04.017
  • Sayiner ZA, Can FI, Akarsu E. Patients’ clinical characteristics and predictors for diabetic foot amputation. Prim Care Diabetes. 2019;13:247–251. doi:10.1016/j.pcd.2018.12.002
  • Shin JY, Roh SG, Sharaf B, et al. Risk of major limb amputation in diabetic foot ulcer and accompanying disease: a meta-analysis. J Plast Reconstr Aesthet Surg. 2017;70:1681–1688. doi:10.1016/j.bjps.2017.07.015
  • Lavery LA, Armstrong DG, Wunderlich RP, et al. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29:1288–1293. doi:10.2337/dc05-2425